Antimicrobial Nanomaterials Battle Biofilm Infection
By HospiMedica International staff writers Posted on 01 Sep 2014 |
An innovative antibacterial gel could be the sought-after breakthrough in the fight against antibiotic-resistant biofilm formation on medical implants.
Developed by researchers at Queen’s University (Belfast, United Kingdom) and Brandeis University (Waltham, MA, USA), the new gel is composed of ultra-short cationic naphthalene-derived self-assembled peptides that form a supramolecular hydrogel at physiological pH, which rapidly kills bacteria such as Pseudomonas aeruginosa, Staphylococcus Aureus, and Escherichia coli. At the same times, the gels possess reduced cytotoxicity relative to the bacterial cells, with limited erythrocyte hemolysis.
In laboratory studies, lysine conjugated variants of the antibacterial gel displayed the greatest potency, significantly reducing the viable Staphylococcus epidermidis biofilm by 94%. Reducing the size of the R-group methylene chain resulted in an even greater reduction of antibiofilm activity. According to the researchers, the self-assembling dipeptides conjugated to naphthalene show considerable promise as nanomaterial structures, biomaterials, and drug delivery devices. The study was published ahead of print on August 7, 2014, in Biomacromolecules.
“When bacteria attach to surfaces, including medical implants such as hip replacements and catheters, they produce a jelly-like substance called biofilm. This protective layer is almost impossible for current antibiotics to penetrate,” said lead author Garry Laverty, PhD, of Queens University School of Pharmacy. “This renders bacteria deep within this protective layer resistant, as they remain unexposed to the therapy. They grow and thrive on surfaces causing difficult to treat infections. The only option often is to remove the medical implant leading to further pain and discomfort for the patient.”
The presence of biofilm bacteria, which thrive on implant surfaces, are a huge burden on healthcare budgets, as they are highly resistant to current therapeutic strategies and often result in infections that are responsible for high rates of patient mortality and morbidity.
Related Links:
Queen’s University
Brandeis University
Developed by researchers at Queen’s University (Belfast, United Kingdom) and Brandeis University (Waltham, MA, USA), the new gel is composed of ultra-short cationic naphthalene-derived self-assembled peptides that form a supramolecular hydrogel at physiological pH, which rapidly kills bacteria such as Pseudomonas aeruginosa, Staphylococcus Aureus, and Escherichia coli. At the same times, the gels possess reduced cytotoxicity relative to the bacterial cells, with limited erythrocyte hemolysis.
In laboratory studies, lysine conjugated variants of the antibacterial gel displayed the greatest potency, significantly reducing the viable Staphylococcus epidermidis biofilm by 94%. Reducing the size of the R-group methylene chain resulted in an even greater reduction of antibiofilm activity. According to the researchers, the self-assembling dipeptides conjugated to naphthalene show considerable promise as nanomaterial structures, biomaterials, and drug delivery devices. The study was published ahead of print on August 7, 2014, in Biomacromolecules.
“When bacteria attach to surfaces, including medical implants such as hip replacements and catheters, they produce a jelly-like substance called biofilm. This protective layer is almost impossible for current antibiotics to penetrate,” said lead author Garry Laverty, PhD, of Queens University School of Pharmacy. “This renders bacteria deep within this protective layer resistant, as they remain unexposed to the therapy. They grow and thrive on surfaces causing difficult to treat infections. The only option often is to remove the medical implant leading to further pain and discomfort for the patient.”
The presence of biofilm bacteria, which thrive on implant surfaces, are a huge burden on healthcare budgets, as they are highly resistant to current therapeutic strategies and often result in infections that are responsible for high rates of patient mortality and morbidity.
Related Links:
Queen’s University
Brandeis University
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure